Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind

Int J Cardiol. 2020 Feb 1:300:198-200. doi: 10.1016/j.ijcard.2019.09.023. Epub 2019 Oct 31.

¹ Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de Valencia, INCLIVA, Valencia, Spain.
² CIBER Cardiovascular; Cardiology Department and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona. Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
³ Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de Valencia, INCLIVA, Valencia, Spain.; CIBER Cardiovascular.

No abstract available

Publication types